CA-QUOTIENT-SCIENCES
11.8.2020 14:02:03 CEST | Business Wire | Press release
ANA Therapeutics , a Silicon Valley-based biotech startup, and Quotient Sciences , a leading provider of innovative drug development and manufacturing solutions, today announced a partnership to support the manufacturing of ANA Therapeutics’ drug candidate, ANA001 (niclosamide capsules), which they are developing as a potential treatment for COVID-19. As part of the collaboration, Quotient will scale up the capsule formulation, characterize and optimize the manufacturing process and ensure continuity of drug product through clinical trials.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200811005106/en/
Laboratory experiments have shown niclosamide stops SARS-CoV-2 (the virus that causes COVID-19) from replicating, making it a promising candidate for reducing the spread of COVID-19. Niclosamide was previously approved by the FDA as a treatment for tapeworm and although not currently marketed in the U.S., it is on the World Health Organization’s List of Essential Medicines and has been used for decades to safely treat millions of people around the world.
“We have selected Quotient Sciences as our development and manufacturing partner and our plan is simple,” said Andrew Bartynski , COO, ANA Therapeutics. “Niclosamide has the potential to be an effective antiviral agent to combat COVID-19, and our top goal is to complete a clinical trial to determine its efficacy in treating patients with COVID-19. Quotient’s speed and agility will play a key role in reaching that important milestone.”
Mark Egerton, Ph.D. , CEO of Quotient Sciences, said, “We are proud to partner with ANA Therapeutics in their pursuit of a treatment to fight this coronavirus pandemic. Our experience and flexible manufacturing approaches will enable ANA Therapeutics to initiate clinical testing in an accelerated timeframe.”
Under the scope of the agreement, ANA Therapeutics will access Quotient’s formulation and manufacturing expertise to develop and rapidly supply drug product for pivotal clinical trials in Q3 2020. The program will be conducted at Quotient’s facility in Garnet Valley, Pennsylvania.
About ANA Therapeutics
ANA Therapeutics is a Silicon Valley-based biotech startup working to develop niclosamide as a safe, widely accessible antiviral treatment for patients with COVID-19. A low-cost, scalable, and well-tolerated compound, niclosamide has the potential to be a needed treatment to help individuals who contract the novel coronavirus to beat it.
About Quotient Sciences
Quotient Sciences is an innovative global pharmaceutical development, clinical and commercial manufacturing organization providing services to the pharmaceutical and biotech industries. A combination of specialized skills and agile integrated processes enables Quotient Sciences to develop customized solutions which dramatically reduce the time and cost of getting drugs to market. Everything we do is driven by a deeply held belief, shared across the entire organization, that molecules need to become cures — fast.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200811005106/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Future Health Launches Global Challenge to Move Health Innovation Towards Real-world Application15.10.2026 13:26:00 CEST | Press release
The Future Health Digital Innovation Challenge 2026 invites entrants to develop AI, software, and connected technology solutions across fertility, population health, and wellbeingSelected teams will gain access to technical and clinical expertise across Abu Dhabi’s health and innovation ecosystem, alongside structured support to refine solutions, test assumptions and develop working prototypes, helping them turn promising ideas into real-world impact fasterSelected solutions may also progress to further validation, incubation, piloting and scale, while three finalists will also share a total prize pool of USD 105,000 at an awards ceremony at GITEX 2026The programme connects global innovation with Abu Dhabi’s clinical, health-system, and technology expertiseInception42, MBZUAI, and Microsoft join as co-creators in the Challenge Future Health – A Global Initiative by Abu Dhabi opened applications for the Future Health Digital Innovation Challenge 2026, welcoming innovators from around th
Hitachi Energy and Rockwell Automation Unite Power and Automation to Help Industries Accelerate Electrification15.10.2026 13:00:00 CEST | Press release
Grid-to-process approach integrates energy supply and production demand to improve efficiency, optimize resources, and simplify complex industrial projects Brings together deep expertise across domains spanning electrical infrastructure, grid and process automation and digital technologies. Supports a more unified approach to planning, delivering, and operating capital-intensive industrial facilities. Initially focused on mining and metals, with potential applications across other energy-intensive industries. Hitachi Energy, a global leader in electrification, and Rockwell Automation, Inc. (NYSE: ROK), the world's largest company dedicated to industrial automation and digital transformation, announced today a collaboration centered on an integrated grid-to-process architecture that combines the infrastructure powering industrial facilities with the systems that manage production. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/
ADFD Strengthens Water Security for Serbian Agriculture15.10.2026 12:45:00 CEST | Press release
Nearly US$100 million in concessional financing is supporting irrigation across 122,432 hectares of agricultural land. Abu Dhabi Fund for Development (ADFD) is strengthening water security and agricultural resilience in Serbia through a nearly US$100 million concessional financing programme supporting irrigation infrastructure across five regions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015388397/en/ Abu Dhabi Fund For Development's Irrigated Agriculture Development Project in Serbia (Photo: AETOSWire) The development of irrigated agriculture project covers 122,432 hectares of agricultural land, with more than 108,000 hectares already irrigated and a further 14,000 hectares under construction. Infrastructure upgrades include 17 irrigation canals extending over 500 kilometres and more than 60 pumping stations, improving water access, strengthening flood control and supporting more reliable agricultural production. D
Venture Global Secures New Agreements to Support Expansion of Existing Grid-Independent Power Network15.10.2026 12:00:00 CEST | Press release
Landmark Agreement with GE Vernova and Baker Hughes supports the development of over 10 GW of new Island-Mode power capacity across sites owned or controlled by Venture GlobalLeverages existing team and execution capabilities to enable rapid deployment of adjacent, behind-the-wall, large-scale data centers with no reliance on the public electric grid demand or extra cost to consumersStaged, market-driven expansion advances Venture Global’s critical energy infrastructure strategy in a disciplined manner and positions the Company to facilitate power and compute capacity at gigawatt-scale on an attractive timeline Venture Global, Inc. (NYSE: VG) today announced it has entered into power and grid frame agreements with GE Vernova and Baker Hughes Energy Services for up to 16 new, 720 MW power island units and associated power transformer equipment, supporting the continued expansion of its existing behind-the-meter, Island-Mode industrial power network that is not reliant on the grid. The a
Moncler Re/Icons: Cher, JENNIE and Grace Jones Re/Define What It Means to Be a Pioneer15.10.2026 12:00:00 CEST | Press release
Since its origins, Moncler has been at the forefront of the ascent, equipping the world’s most intrepid pioneers – those first to explore, so others can follow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015573482/en/ MONCLER RE/ICONS CHER That spirit lives on in the new Moncler Re/Icons collection, which takes iconic styles from the brand’s archives and reimagines them for a new generation, brought to life by three cultural pioneers who have forged their own extraordinary paths: Cher, JENNIE and Grace Jones. Each has spent a career making moves, moving mountains and reaching for higher peaks, refusing to follow the path already laid out before them. Pioneers in their own singular ways, they have blazed trails for others to follow and built enduring legacies that continue to shape what comes next. Inspired by archival photographs of alpine pioneer and early Moncler collaborator Lionel Terray, the campaign brings our p
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom